IDEAYA Biosciences Inc
NASDAQ:IDYA
Income Statement
Earnings Waterfall
IDEAYA Biosciences Inc
Income Statement
IDEAYA Biosciences Inc
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
9
N/A
|
20
+118%
|
27
+37%
|
36
+33%
|
36
+0%
|
28
-21%
|
32
+15%
|
29
-9%
|
50
+71%
|
51
+2%
|
47
-7%
|
45
-5%
|
23
-48%
|
23
0%
|
16
-34%
|
12
-23%
|
4
-67%
|
7
+78%
|
7
N/A
|
7
N/A
|
215
+2 969%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(36)
|
(40)
|
(44)
|
(42)
|
(44)
|
(47)
|
(48)
|
(50)
|
(55)
|
(59)
|
(66)
|
(73)
|
(78)
|
(87)
|
(96)
|
(104)
|
(113)
|
(122)
|
(130)
|
(142)
|
(158)
|
(175)
|
(203)
|
(229)
|
(334)
|
(367)
|
(391)
|
(424)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(7)
|
(9)
|
(10)
|
(11)
|
(13)
|
(14)
|
(15)
|
(17)
|
(17)
|
(19)
|
(20)
|
(21)
|
(22)
|
(23)
|
(24)
|
(24)
|
(26)
|
(27)
|
(28)
|
(30)
|
(33)
|
(35)
|
(39)
|
(44)
|
(49)
|
(56)
|
|
| Research & Development |
(32)
|
(35)
|
(37)
|
(33)
|
(34)
|
(35)
|
(35)
|
(36)
|
(40)
|
(42)
|
(49)
|
(54)
|
(58)
|
(66)
|
(74)
|
(81)
|
(90)
|
(98)
|
(104)
|
(115)
|
(130)
|
(144)
|
(170)
|
(193)
|
(295)
|
(323)
|
0
|
(294)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(342)
|
(74)
|
|
| Operating Income |
(36)
N/A
|
(40)
-11%
|
(44)
-9%
|
(42)
+5%
|
(44)
-5%
|
(47)
-5%
|
(48)
-3%
|
(41)
+14%
|
(35)
+15%
|
(32)
+9%
|
(30)
+5%
|
(37)
-22%
|
(50)
-35%
|
(55)
-10%
|
(67)
-21%
|
(54)
+19%
|
(63)
-15%
|
(75)
-19%
|
(85)
-14%
|
(119)
-40%
|
(134)
-13%
|
(159)
-18%
|
(191)
-20%
|
(225)
-17%
|
(327)
-45%
|
(360)
-10%
|
(384)
-7%
|
(209)
+46%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
6
|
11
|
16
|
21
|
30
|
38
|
47
|
52
|
53
|
0
|
37
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
53
|
12
|
|
| Pre-Tax Income |
(34)
N/A
|
(38)
-11%
|
(42)
-10%
|
(40)
+5%
|
(42)
-6%
|
(44)
-6%
|
(46)
-4%
|
(40)
+13%
|
(35)
+14%
|
(31)
+9%
|
(30)
+5%
|
(37)
-22%
|
(50)
-36%
|
(55)
-10%
|
(66)
-20%
|
(53)
+20%
|
(59)
-11%
|
(68)
-16%
|
(74)
-9%
|
(103)
-39%
|
(113)
-9%
|
(129)
-14%
|
(154)
-19%
|
(178)
-16%
|
(274)
-54%
|
(307)
-12%
|
(331)
-8%
|
(160)
+52%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(34)
|
(38)
|
(42)
|
(40)
|
(42)
|
(44)
|
(46)
|
(40)
|
(35)
|
(31)
|
(30)
|
(37)
|
(50)
|
(55)
|
(66)
|
(53)
|
(59)
|
(68)
|
(74)
|
(103)
|
(113)
|
(129)
|
(154)
|
(178)
|
(274)
|
(307)
|
(331)
|
(160)
|
|
| Net Income (Common) |
(34)
N/A
|
(38)
-11%
|
(42)
-10%
|
(40)
+5%
|
(42)
-6%
|
(44)
-6%
|
(46)
-4%
|
(40)
+13%
|
(35)
+14%
|
(31)
+9%
|
(30)
+5%
|
(37)
-22%
|
(50)
-36%
|
(55)
-10%
|
(66)
-20%
|
(53)
+20%
|
(59)
-11%
|
(68)
-16%
|
(74)
-9%
|
(103)
-39%
|
(113)
-9%
|
(129)
-14%
|
(154)
-19%
|
(178)
-16%
|
(274)
-54%
|
(307)
-12%
|
(331)
-8%
|
(160)
+52%
|
|
| EPS (Diluted) |
-1.76
N/A
|
-1.96
-11%
|
-2.06
-5%
|
-1.97
+4%
|
-3.36
-71%
|
-2.19
+35%
|
-2.19
N/A
|
-1.41
+36%
|
-1.4
+1%
|
-0.99
+29%
|
-0.91
+8%
|
-0.97
-7%
|
-1.41
-45%
|
-1.41
N/A
|
-1.71
-21%
|
-1.28
+25%
|
-1.42
-11%
|
-1.41
+1%
|
-1.31
+7%
|
-1.72
-31%
|
-1.96
-14%
|
-1.71
+13%
|
-1.97
-15%
|
-2.06
-5%
|
-3.36
-63%
|
-3.47
-3%
|
-3.76
-8%
|
-1.78
+53%
|
|